DARK SECRETS: 3 | Vintage Vibes

Texas Sues Johnson & Johnson for 'Hiding' Tylenol Autism Risks — Billions at Stake in Landmark Case

Texas sues Tylenol's makers over autism risks, echoing Trump-era legal battles over health misinformation with potential billions at stake.

International Business Times UK · Oct 30, 2025

Texas sues Tylenol makers alleging deceptive marketing to pregnant people

Lawsuit comes after Trump’s baseless claims that acetaminophen can cause autism and ADHD in children

The Guardian - US · Oct 28, 2025

Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety

Texas Attorney General Ken Paxton has filed a lawsuit against Johnson Johnson (NYSE:JNJ) and Kenvue Inc (NYSE:KVUE), accusing the companies of misleading pregnant women about the safety of Tylenol despite evidence suggesting its active ingredient, acetaminophen, may increase the risk of autism and attention disorders in children.

Benzinga · Oct 28, 2025

Unusually Active: 4 Options to Watch Next Month for Potential Future Gains

Overall options volume was about average on Thursday, with calls accounting for 60% of the action. Of the 1,291 unusually active options on the day, here are four to watch in the next month.

Barchart · Oct 24, 2025

Neutrogena makeup remover face wipes recalled in these states over bacteria concerns

More than 1,000 cases of the Neutrogena Makeup Remover Ultra-Soft Cleansing Towelettes have been recalled

The Independent UK · Oct 24, 2025

Kenvue's Quarterly Earnings Preview: What You Need to Know

Kenvue is expected to announce its third-quarter results by early November, and analysts expect a notable decline in earnings.

Barchart · Oct 23, 2025

Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.

The former consumer health unit of Johnson & Johnson remains mired in troubles surrounding Tylenol.

Barchart · Oct 22, 2025

This Billionaire Investor Is ‘Thrilled’ to Own Kenvue Stock Despite Tylenol Turbulence. Should You Buy KVUE Here?

Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during pregnancy.

Barchart · Oct 22, 2025

64-Year-Old Blames Johnson & Johnson for Her Ovarian Cancer — Joins 3,000 Suing the Pharma Giant

UK's first talc cancer group claim accuses Johnson & Johnson and Kenvue of failing to warn about asbestos risk — £1 billion suit backed by 3,000 claimants.

International Business Times UK · Oct 16, 2025

Thousands in UK take legal action against Johnson & Johnson over alleged talc cancer link

High court claim says company knowingly sold product containing asbestos and ‘concealed’ risk to public

The Guardian - UK · Oct 16, 2025